tirzepatide substitute Eli Lilly sues companies selling alternative versions of its weight loss drug Tirzepatide vs. Semaglutide for Weight

Sasha Buchert, counsel for Lambda Legal, said her group, along with the Human Rights Campaign, also plans to file a legal challenge

Recent studies, including new research published in Nature Medicine (Jan 2025), suggest that these medications carry risks beyond short-term nausea or digestive issues

BMJ Open Diabetes Res Care 8(2):e001649 Furusawa S, Nomoto H, Yokoyama H, Suzuki Y, Tsuzuki A, Takahashi K, Miya A, Kameda H, Cho KY, Takeuchi J, Nagai S, Taneda S, Kurihara Y, Nakamura A, Atsumi T (2023) Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: a multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study)

Complete an online consultation which will enable our medical team to assess the suitability of the weight loss medication for you and place your order